Long-term Safety, Tolerability, and Effectiveness of TV-46000, a Long-Acting Subcutaneous Antipsychotic (LASCA), in Patients With Schizophrenia (SHINE)

Authors
Category Primary study
ConferenceNeuroscience Education Institute Congress, NEI 2023
Year 2024
This article has no abstract
Epistemonikos ID: af6e74a8b04cf601d5d227c036788b1292ed7ffd
First added on: Apr 19, 2025